Clinical Trials

50 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT06088290 2026-03-11

SaLuDo

450 enrolled

Sarcoma

Leiomyosarcoma, Neoplasms

NCT06901531 2026-03-11

LUCERNA

500 enrolled

Phase 3 Not yet recruiting

Adenocarcinoma, Neoplasms

NCT07464145 2026-03-11

RESCUE

393 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

NCT03844048 2026-03-06

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

LymphoidOther hematologic neoplasmPlasma cell

165 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06691984 2026-03-06

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

675 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT04222972 2026-03-05

AcceleRET-Lung

Phase 3 Terminated

223 enrolled 18 charts

Head & NeckThoracic

Adenocarcinoma, Bronchial Diseases, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT07195591 2026-03-04

BRIDGES

766 enrolled

CNS

Glioblastoma, Neoplasms

NCT05154162 2026-03-03

PRIMARY2

660 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT06191744 2026-03-03

EPCORE™FL-2

1,095 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT01602380 2026-02-27

FALCON

462 enrolled 20 charts

Neoplasm Metastasis, Neoplasms

NCT01909453 2026-02-27

COLUMBUS

921 enrolled 48 charts 1 FDA

Dermatologic

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

NCT05377554 2026-02-27

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

154 enrolled

Neoplasms

NCT05920356 2026-02-27

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

750 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06252649 2026-02-27

CodeBreaK 301

450 enrolled

Neoplasms, Colorectal Neoplasms

NCT05051735 2026-02-25

PARASTOP

Phase 3 Enrolling by invitation

204 enrolled

Cancer Pain, Neoplasms, Pain

NCT05303532 2026-02-23

ROSY-D

214 enrolled

Neoplasms

NCT05445778 2026-02-23

GLORIOSA

520 enrolled

Gynecologic

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT03194893 2026-02-20

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

200 enrolled

EndocrineThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Multiple Endocrine Neoplasia Type 2a

NCT05804032 2026-02-18

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

514 enrolled

LymphoidPlasma cell

Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Paraproteinemias

NCT03504397 2026-02-13

Spotlight

565 enrolled 63 charts 1 FDA

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT03653507 2026-02-06

GLOW

507 enrolled 65 charts 1 FDA

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT07005024 2026-02-05

DOAC

996 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT07022483 2026-02-04

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

710 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT05061823 2026-02-02

Bintrafusp Alfa Program Rollover Study

22 enrolled 11 charts

Lung Neoplasms, Neoplasms

NCT03768063 2026-01-29

IMbrella B

1,000 enrolled

Neoplasms

NCT03979014 2026-01-29

NOVEL

1,099 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT05223647 2026-01-28

TRIPLEX

Phase 3 Terminated

239 enrolled

Phase 3 Not yet recruiting

Neoplasms, Small Cell Lung Carcinoma

NCT07365241 2026-01-26

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

531 enrolled

Neoplasms, Small Cell Lung Carcinoma

NCT07366528 2026-01-26

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

387 enrolled

Neoplasms, Stomach Neoplasms

NCT06135415 2026-01-22

TirbAKare

DermatologicOther neoplasm

280 enrolled

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT04421963 2026-01-21

ROSY-O

185 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT04964934 2026-01-16

SERENA-6

315 enrolled

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT05053867 2026-01-14

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

60 enrolled

Neoplasms

NCT03148418 2026-01-13

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

382 enrolled

Neoplasms

NCT04906395 2026-01-13

OVELIA

250 enrolled

Phase 3 Enrolling by invitation

Breast Neoplasms, Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

250 enrolled

Breast Neoplasms, Neoplasms

NCT05112965 2026-01-07

An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

49 enrolled

Neoplasms

NCT06072612 2026-01-06

BRIA-ABC

404 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT04442048 2025-12-30

COV-IMMUNO

195 enrolled

COVID-19, Neoplasms

NCT06881992 2025-12-30

Tumor HI